Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Intermedia Capital Tbk. (MDIA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Intermedia Capital Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Intermedia Capital Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Intermedia Capital Tbk. trades at Rp216 (market cap 8.08T, 258.28M 24h volume). The key difference: Intermedia Capital Tbk. is far larger — about 11.7× UBC Medical Indonesia Tbk.'s market cap, and Intermedia Capital Tbk. is more actively traded (258.28M versus 635.5K). Which is the better fit depends on your goals.

LABSMDIA
Market Cap
691.25B8.08T
Volume
635.5K258.28M
Lot
6.36K2.58M
Turnover
110.15M53.87B
Average Price
173.33208.59
Value
110.15M53.87B
Indicative Equilibrium Price
174216
Indicative Equilibrium Volume
5058.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MDIA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Intermedia Capital Tbk.

PT Intermedia Capital Tbk (the Company) was established based on Notarial Deed No.5 of Firdhonal, S.H., dated February 25, 2008 under the name of PT Magazine Asia.

Read more on MDIA